ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,941,971 | -19.8% | 1,341,549 | +0.5% | 0.00% | – |
| Q2 2023 | $9,900,372 | -18.4% | 1,334,282 | +3.9% | 0.00% | – |
| Q1 2023 | $12,132,855 | +2.0% | 1,283,900 | +14.9% | 0.00% | – |
| Q4 2022 | $11,896,593 | +50.8% | 1,117,051 | +4.5% | 0.00% | – |
| Q3 2022 | $7,889,000 | +53.4% | 1,068,947 | 0.0% | 0.00% | – |
| Q2 2022 | $5,142,000 | +17.2% | 1,068,947 | +24.5% | 0.00% | – |
| Q1 2022 | $4,388,000 | -15.6% | 858,837 | -0.8% | 0.00% | – |
| Q4 2021 | $5,202,000 | -32.3% | 865,589 | -0.1% | 0.00% | – |
| Q3 2021 | $7,679,000 | +18.4% | 866,731 | +5.7% | 0.00% | – |
| Q2 2021 | $6,483,000 | +48.6% | 819,642 | +43.2% | 0.00% | – |
| Q1 2021 | $4,363,000 | +0.1% | 572,520 | +2.5% | 0.00% | – |
| Q4 2020 | $4,358,000 | -10.9% | 558,780 | +10.8% | 0.00% | – |
| Q3 2020 | $4,889,000 | – | 504,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Interchange Capital Partners, LLC | 11,420 | $90,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 47,097 | $373,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $80,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99,166 | $784,000 | 0.01% |
| EMFO, LLC | 1,666 | $13,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 34,333 | $272,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 51,466 | $407,000 | 0.00% |
| Tarbox Family Office, Inc. | 332 | $3,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,808 | $30,000 | 0.00% |